[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 4, Number 52 (12-2014) ::
JMP 2014, 4(52): 81-88 Back to browse issues page
Safety and Efficacy of Processed Citrullus colocynthis L. Fruit in Treatment of Hyperlipidemic Type II Diabetic Patients: A Randomized, Placebo-controlled Clinical Trial
M Yaghoobi1, E Miri-Moghaddam2, A Navidian3, R Nikbakht4, A Mehrafarin5, H Fallah Huseini *6
1- (M.Sc.) 1- Pregnancy Health Research Center, Zahedan University of Medical Sciences, Zahedan, Iran
2- (Ph.D.) 2- Department of Genetics, Zahedan University of Medical Sciences, Zahedan, Iran
3- (Ph.D.) 1- Pregnancy Health Research Center, Zahedan University of Medical Sciences, Zahedan, Iran
4- (B.Sc.) 3- Student Research Committee, Kerman University of Medical Sciences, Kerman, Iran
5- (Ph.D.) 4- Cultivation & Development Department of Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran
6- (Ph.D.) 5- Pharmacology & Applied Medicine Department of Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran , huseini_fallah@yahoo.com
Abstract:   (2524 Views)
Background: Due to high prevalence of diabetes with hyperlipidemia and associated high risk of cardiovascular disease, much interest exists for safe medications including medicinal plants. Considering traditional use of Citrullus colocynthis L. (C. colocynthis) for treatment of diabetes and hyperlipidemia despite toxicity, clinical evaluation of safety and efficacy of the processed C. colocynthis fruit is necessary. Objective: In this clinical trial the safety and efficacy of the processed C. colocynthis fruit in hyperlipidemic type II diabetic patients were evaluated. Methods: 60 hyperlipidemic type 2 diabetic patients were randomly allocated to C. colocynthis and placebo groups, but only 28 patients in each group completed the study. The patients in C. colocynthis and placebo groups were treated with processed C. colocynthis (100 mg) and placebo capsules (100 mg) three times a day respectively for 1 month. The fasting blood glucose, cholesterol, LDL, HDL, and triglyceride levels as primary outcome and aspartate transaminase, alanine transaminase and creatinine levels as secondary outcome were measured in both groups at the baseline and the endpoint. Results: In the C. colocynthis group fasting blood glucose, cholesterol and LDL levels were significantly reduced at the endpoint compared with the baseline. There were no significant changes in any blood parameters in C. colocynthis group compared with placebo at the endpoint. There were no gastrointestinal, liver and kidney function adverse effects during the study in both groups. Conclusion: The results suggest that processed C. colocynthis fruit extract may be a safe anti-hyperglycemic and anti-hypercholesterolemic agent in hyperlipidemic type II diabetic patients.
Keywords: C. colocynthis, Hyperlipidemia, Medicinal plants, Type II diabetes
Full-Text [PDF 208 kb]   (979 Downloads)    
Type of Study: Research | Subject: Pharmacology
Received: 2015/01/28 | Accepted: 2015/01/28 | Published: 2015/01/28
Send email to the article author

Add your comments about this article
Your username or email:

Write the security code in the box >



XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Yaghoobi M, Miri-Moghaddam E, Navidian A, Nikbakht R, Mehrafarin A, Fallah Huseini H. Safety and Efficacy of Processed Citrullus colocynthis L. Fruit in Treatment of Hyperlipidemic Type II Diabetic Patients: A Randomized, Placebo-controlled Clinical Trial. JMP. 2014; 4 (52) :81-88
URL: http://jmp.ir/article-1-874-en.html
Volume 4, Number 52 (12-2014) Back to browse issues page
فصلنامه علمی پژوهشی گیاهان دارویی Journal of Medicinal Plants
Persian site map - English site map - Created in 0.051 seconds with 800 queries by yektaweb 3461